Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Athira Pharma
Athira Pharma
Athira’s losing streak continues with phase 2 failure in dementia
Fierce Biotech
Tue, 12/12/23 - 11:09 am
Athira Pharma
clinical trials
dementia
fosgonimeton
Athira’s Alzheimer’s Therapy Climbs Ranks in a Competitive Space
BioSpace
Fri, 12/2/22 - 11:08 am
Athira Pharma
Alzheimer's disease
fosgonimeton
Sometimes, Clinical Trials Miss the Mark: Neurocrine, Akebia, Eliem and Athira
BioSpace
Fri, 08/5/22 - 10:57 am
clinical trials
Neurocrine Biosciences
Akebia Therapeutics
Eliem Therapeutics
Athira Pharma
Athira Puts Positive Spin on Alzheimer’s Trial Despite Missed Endpoint
BioSpace
Wed, 06/22/22 - 10:28 am
Athira Pharma
fosgonimeton
Alzheimer's disease
clinical trials
Significant readouts for small players
EP Vantage
Thu, 03/31/22 - 10:22 am
clinical trials
SAGE Therapeutics
Biogen
Relmada
Athira Pharma
TauRx
Athira Looks to Advance Alzheimer’s, Parkinson’s Disease Research Amid CEO Debacle
BioSpace
Wed, 08/18/21 - 11:01 am
Athira Pharma
CEO
Alzheimer's disease
Parkinson's Disease
R&D
Athira Pharma in Crosshairs of Legal Action Over Data Manipulation Charges
BioSpace
Thu, 08/5/21 - 11:03 pm
Athira Pharma
data manipulation
Athira Pharma CEO placed on leave after questions about her doctoral research, shares sink more than 30%
Geekwire
Fri, 06/18/21 - 10:20 am
Athira Pharma
Leen Kawas
Pharma CEOs
Seattle-based Athira, aiming for tough Alzheimer's and Parkinson's targets, raises $204M fo
Endpoints
Fri, 09/18/20 - 10:58 am
Athira Pharma
IPOs
Alzheimer's disease
Parkinson's Disease
Athira Aims for the Nasdaq to Advance Alzheimer’s Drug to Phase 2 Tests
Xconomy
Thu, 08/27/20 - 10:25 pm
Athira Pharma
Alzheimer's disease
clinical trials
ATH-1017
Can a small biotech successfully tackle an Everest climb like Alzheimer’s? Athira has $85M and some influential backers ready to give it a shot
Endpoints
Sat, 06/6/20 - 03:08 pm
Alzheimer's disease
Athira Pharma
clinical trials
Alzheimer's-focused M3 Biotechnology rebrands as Athira Pharma
Fierce Biotech
Fri, 04/12/19 - 12:04 am
M3 Biotechnology
rebranding
Athira Pharma
Alzheimer's disease